Advertisement

Topics

RECORDATI CORPORATION Company Profile

04:52 EST 14th December 2018 | BioPortfolio

Recordati, established in 1926, is a European pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), dedicated to the research, development, manufacturing and marketing of pharmaceuticals, with headquarters in Milan, Italy, operations in the main European countries, and a total staff of over 2,000. A European field force of over 1,000 medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas. Recordati’s current and growing coverage of the European pharmaceutical market makes it a partner of choice for new product licenses from companies which do not have European marketing organizations. Recordati is committed to the research of new drug entities within the cardiovascular and urogenital therapeutic areas in which its research team has proven scientific competence and a track record of discovery and development of original drugs, the most recent of which, lercanidipine, a latest generation calcium channel blocker for the treatment of hypertension, is the company’s leading product. Consolidated revenue for 2005 was € 576.1 million, operating income was € 111.1 million and net income was € 64.5 million.

Location

502 Centennial AvenueP.O. Box 160
Cranford
New Jersey
07016
United States of America

Contact

Phone: 1 908 272 7220
Fax: 39 02 40073747
Email: comimagen@recordati.it


News Articles [102 Associated News Articles listed on BioPortfolio]

CVC to buy majority stake in drugmaker Recordati for €3bn

Private equity firm CVC Capital Partners has signed an agreement to acquire a 51.8% stake in Italian pharmaceutical group Recordati...Read More... The post CVC to buy majority stake in drugmaker Recor...

CVC-led consortium to buy majority stake in Recordati for EUR3.03bn

Private equity firm CVC Capital Partners-led consortium has agreed to acquire controlling stake in Italian drugmaker, Recordati, in a deal valued at €3.03bn.

Recordati Founding Family Sells €3bn Stake As PE Digs Deeper Into Pharma

With private equity interest in the health space booming, CVC has taken a controlling stake in Recordati for €3.03bn, at...    

European OTC Shifts: BMS Eyes Selling French Business, Private Equity Controls Italy's Recordati

Bristol-Myers Squibb weighs selling its UPSA French OTC business, conducting a strategic review to assess its growth potential. Milan-based Recordati...   

Recordati Rare Diseases Canada Inc. Announces the Canadian Launch of PANHEMATIN®

Recordati Rare Diseases Canada Inc., a biopharmaceutical company providing orphan therapies for patients with rare diseases, today announced the commercial launch of PANHEMATIN®,...

CVC fund to acquire controlling stake in Recordati

CVC led consortium to buy majority stake in Recordati pharma business

RECORDATI RECEIVES ORPHAN DRUG DESIGNATION FOR ITS INVESTIGATIONAL TREATMENT FOR MSUD

RECORDATI RECEIVES ORPHAN DRUG DESIGNATION FOR ITS INVESTIGATIONAL TREATMENT FOR MSUD Milan, 5 November 2018 –Recordati today announced that the European Commission (EC) has granted Orphan Drug D...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [180 Associated Companies listed on BioPortfolio]

Recordati Rare Diseases Canada Inc.

Recordati Rare Diseases Canada Inc. is a biopharmaceutical company committed to providing often overlooked orphan therapies to underserved rare disease communities in Canada. Reco...

RECORDATI CORPORATION

Recordati, established in 1926, is a European pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), dedicated to the research, development...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

ALFRED E. TIEFENBACHER (GmbH & Co. KG)

AET started out in 1963 as a pioneer in the newly developing international active pharmaceutical ingredient business. In a time when there still was no direct telephone service berween the two countri...

More Information about "RECORDATI CORPORATION" on BioPortfolio

We have published hundreds of RECORDATI CORPORATION news stories on BioPortfolio along with dozens of RECORDATI CORPORATION Clinical Trials and PubMed Articles about RECORDATI CORPORATION for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of RECORDATI CORPORATION Companies in our database. You can also find out about relevant RECORDATI CORPORATION Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Corporate Database Quicklinks



Searches Linking to this Company Record